ABSL-3 facilities for in-vivo work are currently only able to support rodent studies. Most research being conducted in the ABSL-3 is dedicated to SARS-Cov2 and the ability to support multi-pathogen work is limited.
The Cardiovascular Regeneration Core Laboratory routinely generates patient-specific human induced pluripotent stem cells (hiPSCs) for basic science research purposes of cardiovascular diseases. We generate chamber specific human cardiac cells (atrial vs. ventricular)...
